Clinical Trial Update: Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives [Phase 1]

View source ↗

Summary

A Phase 1 trial by GlaxoSmithKline evaluating the potential for orthostatic hypotension in elderly hypertensive individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension | Phase 1 | Status: COMPLETED